Navigation Links
NxStage(R) to Report Third Quarter 2009 Financial Results

LAWRENCE, Mass., Oct. 15 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the third quarter ended September 30, 2009 on Thursday, November 5, 2009 before the opening of the financial markets.

NxStage will also host a conference call at 9:00 a.m. Eastern Time on Thursday, November 5, 2009 to discuss its third quarter financial results. To listen to the conference call, please dial 866-761-0749 (domestic) or 617-614-2707 (international). The passcode is 89787973. The call will also be webcast LIVE and can be accessed via the investor relations section of the Company's website at

A replay of the conference call will be available 3 hours after the start of the call through November 19, 2009. To access the replay dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter passcode 53620507. An online archive of the conference call can be accessed via the investor relations section of the Company's website at

About NxStage

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. The forward-looking statements in this release include NxStage's plan to release its financial results on November 5, 2009. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, unexpected difficulty in closing the company's financial books for the quarter and other factors that are discussed in NxStage's Quarterly Report on Form 10-Q for the period ended June 30, 2009 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

    Contact: Kristen K. Sheppard, Esq., VP,  Investor Relations

SOURCE NxStage Medical, Inc.

SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
2. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
3. Weekly Digests Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 Swine Flu Outbreak
4. Escalon(R) Reports Fourth Quarter and Fiscal 2009 Results
5. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
6. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
7. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
8. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
9. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
10. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
11. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... the addition of the  "Global Drug ...  report to their offering.  --> ... addition of the  "Global Drug Device ... to their offering.  --> ...
(Date:11/24/2015)... -- The hope of bearing a child ... cycles. After failure of over 15 IVF cycles, Mrs. ... hopes that she would be able to conceive ever. But finally optimism prevailed as she ... of over 15 IVF cycles. India ... one last attempt with Gaudium IVF Center in New ...
(Date:11/24/2015)... Nov. 25, 2015 WuXi PharmaTech (Cayman) Inc. ... leading open-access R&D capability and technology platform company serving ... in China and ... an extraordinary general meeting of shareholders held today, the ... authorize and approve the previously announced agreement and plan ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... New patients who wish to ... for dental implants at her Mississauga, ON practice. Dr. Williams has been ... placement of dental implants. , Missing teeth can lead to a variety of ...
(Date:11/24/2015)... ... , ... In an article published November 12th by Obesity News ... or are not eligible for bariatric surgery. The article explains that candidates for weight ... 100 pounds overweight, or have a BMI of 35 and over with at least ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Preparing for the ... – 3:00 p.m. EST, , FDA has long asserted that design ... apply to performing the tests and do not meet the device regulations. , Come ...
(Date:11/24/2015)... FL (PRWEB) , ... November 24, 2015 , ... In ... a growing epidemic as deaths from prescription opioids in the United States grew 400 ... cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal drug ...
(Date:11/24/2015)... ... November 24, 2015 , ... American Family Care (AFC), the nation’s leading ... holiday pop-up clinic located in Metro Atlanta’s North Point Mall. The clinic is designed ... way. The location is scheduled to operate through Dec. 24. , Holiday Pop-Up Clinic ...
Breaking Medicine News(10 mins):